TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2
- 28 June 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (29), 3757-3765
- https://doi.org/10.1038/sj.onc.1204504
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 42 references indexed in Scilit:
- Overexpression of Bcl2 Blocks TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis in Human Lung Cancer CellsBiochemical and Biophysical Research Communications, 2001
- APOPTOSIS-INDUCED BY TRAIL AND TNF-α IN HUMAN MULTIPLE MYELOMA CELLS IS NOT BLOCKED BY BCL-2Cytokine, 1999
- Death Receptors: Signaling and ModulationScience, 1998
- Apoptosis Induction by Caspase-8 Is Amplified through the Mitochondrial Release of Cytochrome cJournal of Biological Chemistry, 1998
- APO2 ligand: a novel lethal weapon against malignant glioma?FEBS Letters, 1998
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.The Journal of cell biology, 1996
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Involvement of an ICE-like protease in Fas-mediated apoptosisNature, 1995